BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 84 filers reported holding BLUEBIRD BIO INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $652,086 | -40.0% | 214,502 | -35.1% | 0.00% | 0.0% |
Q2 2023 | $1,086,677 | -44.2% | 330,297 | -46.1% | 0.00% | -66.7% |
Q1 2023 | $1,947,725 | +34.1% | 612,492 | +191.9% | 0.00% | +50.0% |
Q4 2022 | $1,452,197 | -99.9% | 209,855 | -36.3% | 0.00% | -33.3% |
Q3 2022 | $2,085,292,000 | +171.0% | 329,430 | +77.2% | 0.00% | +200.0% |
Q2 2022 | $769,605,000 | -38.8% | 185,895 | -28.3% | 0.00% | -50.0% |
Q1 2022 | $1,257,668,000 | -57.6% | 259,313 | -12.7% | 0.00% | -50.0% |
Q4 2021 | $2,966,980,000 | +57.0% | 296,995 | +200.3% | 0.00% | +33.3% |
Q3 2021 | $1,889,711,000 | -22.7% | 98,886 | +29.4% | 0.00% | 0.0% |
Q2 2021 | $2,443,848,000 | +60.3% | 76,418 | +51.1% | 0.00% | +50.0% |
Q1 2021 | $1,524,957,000 | -38.1% | 50,579 | -11.1% | 0.00% | -60.0% |
Q4 2020 | $2,462,106,000 | +51.0% | 56,901 | +88.3% | 0.01% | +150.0% |
Q3 2020 | $1,630,531,000 | +47.2% | 30,223 | +66.6% | 0.00% | 0.0% |
Q2 2020 | $1,107,510,000 | -24.1% | 18,144 | -42.9% | 0.00% | -33.3% |
Q1 2020 | $1,460,103,000 | +18.2% | 31,769 | +125.6% | 0.00% | +50.0% |
Q4 2019 | $1,235,783,000 | -79.0% | 14,083 | -78.0% | 0.00% | -80.0% |
Q3 2019 | $5,872,073,000 | +133.0% | 63,952 | +222.7% | 0.01% | +100.0% |
Q2 2019 | $2,520,595,000 | +25.5% | 19,816 | +55.2% | 0.01% | +25.0% |
Q1 2019 | $2,008,317,000 | +9.5% | 12,765 | -30.9% | 0.00% | 0.0% |
Q4 2018 | $1,833,514,000 | +1.5% | 18,483 | +49.5% | 0.00% | +33.3% |
Q3 2018 | $1,805,582,000 | +6.2% | 12,367 | +14.2% | 0.00% | 0.0% |
Q2 2018 | $1,700,239,000 | -53.2% | 10,833 | -49.1% | 0.00% | -57.1% |
Q1 2018 | $3,633,048,000 | +103.0% | 21,277 | +111.7% | 0.01% | +133.3% |
Q4 2017 | $1,789,727,000 | +139.4% | 10,049 | +84.6% | 0.00% | +50.0% |
Q3 2017 | $747,733,000 | +39.2% | 5,444 | +6.5% | 0.00% | 0.0% |
Q2 2017 | $537,226,000 | +610.3% | 5,114 | +514.7% | 0.00% | – |
Q1 2017 | $75,629,000 | -57.2% | 832 | -71.0% | 0.00% | -100.0% |
Q4 2016 | $176,832,000 | -15.4% | 2,866 | -7.1% | 0.00% | 0.0% |
Q3 2016 | $209,034,000 | +229.6% | 3,084 | +110.5% | 0.00% | – |
Q2 2016 | $63,420,000 | +268.4% | 1,465 | +261.7% | 0.00% | – |
Q1 2016 | $17,213,000 | -66.2% | 405 | -49.0% | 0.00% | – |
Q4 2015 | $50,990,000 | -73.6% | 794 | -64.9% | 0.00% | – |
Q3 2015 | $193,257,000 | +64.2% | 2,259 | +223.2% | 0.00% | – |
Q2 2015 | $117,691,000 | +109.1% | 699 | +50.0% | 0.00% | – |
Q1 2015 | $56,279,000 | +22.6% | 466 | -63.6% | 0.00% | – |
Q3 2014 | $45,891,000 | +604.1% | 1,279 | +656.8% | 0.00% | – |
Q2 2014 | $6,518,000 | +789.2% | 169 | +356.8% | 0.00% | – |
Q1 2014 | $733,000 | +16.5% | 37 | +23.3% | 0.00% | – |
Q4 2013 | $629,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
RA Capital Management | 167,367 | $14,318,000 | 2.06% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |